Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix

Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix

Objective This study elucidated the efficacy of Relugolix (REL) on the reduction of uterine volume and clinical symptoms for the treatment of adenomyosis.Methods We conducted a retrospective cohort study of patients who received REL (40 mg for about 20 weeks) and who underwent a hysterectomy for ade...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Keitaro Yamanaka, Keiichi Washio, Akiko Uchida, Yuki Sasagawa, Masashi Nishimoto, Yui Yamasaki, Satoshi Nagamata, Yoshito Terai
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Taylor & Francis Group 2023-12-01
Loạt:Gynecological Endocrinology
Những chủ đề:
Adenomyosis
relugolix
fibroids
GnRH antagonist
GnRH agonist
Truy cập trực tuyến:https://www.tandfonline.com/doi/10.1080/09513590.2023.2237121

Internet

https://www.tandfonline.com/doi/10.1080/09513590.2023.2237121

Những quyển sách tương tự